OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 48 filers reported holding OMEGA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,270,146 | -61.6% | 1,055,882 | 0.0% | 0.90% | -49.8% |
Q2 2023 | $5,912,938 | -7.1% | 1,055,882 | 0.0% | 1.79% | +6.2% |
Q1 2023 | $6,366,969 | +5.6% | 1,055,882 | 0.0% | 1.69% | +5.2% |
Q4 2022 | $6,029,085 | +5.3% | 1,055,882 | 0.0% | 1.61% | +4.4% |
Q3 2022 | $5,723,000 | +42.6% | 1,055,882 | 0.0% | 1.54% | +0.5% |
Q2 2022 | $4,012,000 | -39.1% | 1,055,882 | 0.0% | 1.53% | -45.3% |
Q1 2022 | $6,589,000 | -44.9% | 1,055,882 | 0.0% | 2.80% | -29.4% |
Q4 2021 | $11,964,000 | -39.9% | 1,055,882 | 0.0% | 3.97% | -31.7% |
Q3 2021 | $19,904,000 | – | 1,055,882 | – | 5.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 352,941 | $6,653,000 | 8.31% |
CHI Advisors LLC | 1,055,882 | $19,904,000 | 5.81% |
Flagship Pioneering Inc. | 25,902,269 | $488,258,000 | 5.11% |
HARBOURVEST PARTNERS LLC | 2,647,059 | $49,897,000 | 4.69% |
Octagon Capital Advisors LP | 370,279 | $6,980,000 | 1.72% |
Monashee Investment Management LLC | 441,176 | $8,316,000 | 1.54% |
Artal Group S.A. | 2,273,530 | $42,856,000 | 0.96% |
SPHERA FUNDS MANAGEMENT LTD. | 527,948 | $9,952,000 | 0.84% |
PLATINUM INVESTMENT MANAGEMENT LTD | 500,000 | $9,425,000 | 0.26% |
Logos Global Management LP | 88,235 | $1,663,000 | 0.12% |